Pancreatic Intraepithelial Neoplasia

 Low grade includes PanIN-1 and PanIN-2


image High grade includes PanIN-3 and carcinoma in situ


• Low grade: Mild to moderate nuclear atypia

• High grade: Marked nuclear atypia, loss of polarity, cribriforming, luminal necrosis




Top Differential Diagnoses




• Intraductal papillary mucinous neoplasm

• Reactive ductal epithelial changes

• Intraductal spread of invasive carcinoma (cancerization of ducts)


Diagnostic Checklist




• High-grade PanIN should be noted in pathology reports, especially in absence of invasive carcinoma

• Low-grade PanIN does not need to be reported, does not affect surgical management

image
Low Grade (PanIN-1)
Pancreatic duct lined by a single layer of epithelium is shown with abundant apical mucinous cytoplasm and basal nuclei that lack atypia [formerly pancreatic intraepithelial neoplasia (PanIN)-1a].


image
Low Grade (PanIN-2)
The lining cells show enlarged hyperchromatic nuclei and a slight loss of nuclear polarity image. The cytologic atypia distinguishes it from PanIN-1. Both PanIN-1 and PanIN-2 are now classified as low-grade PanIN.

image
Low-grade PanIN, Micropapillary Pattern
Pancreatic duct lined by a micropapillary proliferation of mucinous epithelial cells image. There is nuclear crowding and hyperchromasia indicating low-grade PanIN. This was formerly referred to as PanIN-2.

image
High-Grade PanIN
The pancreatic duct is lined by epithelial cells with micropapillary architecture, prominent cytologic atypia, variably prominent nucleoli, and loss of polarity (formerly referred to as PanIN-3).


TERMINOLOGY


Abbreviations




• Pancreatic intraepithelial neoplasia (PanIN)


Synonyms




• Dysplasia, carcinoma in situ


Definitions




• Noninvasive pancreatic intraductal epithelial proliferation, likely precursor of pancreatic ductal adenocarcinoma


ETIOLOGY/PATHOGENESIS


Molecular Progression




• Early: Telomerase shortening, KRAS2 activation

• Intermediate: Inactivation of p16/ CDKN2A

• Late: Inactivation of TP53, DPC4 / SMAD4

• p16 inactivation is seen in ∼ 30-50% low-grade, 70% high grade, 95% ductal adenocarcinomas

• KRAS mutation is seen in ∼ 40-80% low-grade, > 80% high-grade, > 90% ductal adenocarcinomas


CLINICAL ISSUES


Natural History




• Low-grade PanIN: Commonly found in resected pancreas; significance unclear

• High-grade PanIN: Associated with significant risk of progression to pancreatic ductal adenocarcinoma

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 20, 2017 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Pancreatic Intraepithelial Neoplasia

Full access? Get Clinical Tree

Get Clinical Tree app for offline access